Published in Infect Immun on September 01, 1993
sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol (2002) 6.71
Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect Immun (1995) 4.58
Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence. Infect Immun (2000) 3.15
Global regulation of Staphylococcus aureus genes by Rot. J Bacteriol (2003) 3.02
Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J Bacteriol (1998) 3.01
Influence of a functional sigB operon on the global regulators sar and agr in Staphylococcus aureus. J Bacteriol (2001) 2.97
Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis (2009) 2.72
Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureus. Infect Immun (2002) 2.71
Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect Immun (2003) 2.59
Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro. Infect Immun (2000) 2.50
Alternative transcription factor sigmaSB of Staphylococcus aureus: characterization and role in transcription of the global regulatory locus sar. J Bacteriol (1997) 2.45
agr function in clinical Staphylococcus aureus isolates. Microbiology (2008) 2.33
Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds. Nat Prod Rep (2009) 2.32
Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc Natl Acad Sci U S A (2005) 2.30
Virulence gene expression in human community-acquired Staphylococcus aureus infection. J Infect Dis (2009) 2.24
The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase. J Bacteriol (2004) 2.18
Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun (1997) 2.13
A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One (2008) 2.12
agr expression precedes escape of internalized Staphylococcus aureus from the host endosome. Infect Immun (2001) 2.11
SarT, a repressor of alpha-hemolysin in Staphylococcus aureus. Infect Immun (2001) 1.89
Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region. J Bacteriol (2004) 1.85
The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun (1997) 1.80
Quorum sensing in Staphylococcus infections. J Clin Invest (2003) 1.79
Transcription of Staphylococcus aureus fibronectin binding protein genes is negatively regulated by agr and an agr-independent mechanism. J Bacteriol (1997) 1.72
Global regulation of gene expression by ArlRS, a two-component signal transduction regulatory system of Staphylococcus aureus. J Bacteriol (2005) 1.72
Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun (1997) 1.69
Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease. Infect Immun (1997) 1.67
Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One (2010) 1.64
Evidence for a signaling system in Helicobacter pylori: detection of a luxS-encoded autoinducer. J Bacteriol (2000) 1.61
Role of sarA in the pathogenesis of Staphylococcus aureus musculoskeletal infection. Infect Immun (2003) 1.60
Evolutionary Trade-Offs Underlie the Multi-faceted Virulence of Staphylococcus aureus. PLoS Biol (2015) 1.55
Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun (1999) 1.52
Structure of the Staphylococcus aureus AgrA LytTR domain bound to DNA reveals a beta fold with an unusual mode of binding. Structure (2008) 1.50
Genetic instability of the global regulator agr explains the phenotype of the xpr mutation in Staphylococcus aureus KSI9051. J Bacteriol (1998) 1.42
Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect Immun (2000) 1.39
MrkH, a novel c-di-GMP-dependent transcriptional activator, controls Klebsiella pneumoniae biofilm formation by regulating type 3 fimbriae expression. PLoS Pathog (2011) 1.36
Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J Immunol (2010) 1.35
Staphylococcus aureus fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intracellular levels of bacteria. Infect Immun (2001) 1.33
Fsr-independent production of protease(s) may explain the lack of attenuation of an Enterococcus faecalis fsr mutant versus a gelE-sprE mutant in induction of endocarditis. Infect Immun (2005) 1.33
The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology (1998) 1.30
Relationship of plcR-regulated factors to Bacillus endophthalmitis virulence. Infect Immun (2003) 1.28
Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses. Infect Immun (2001) 1.28
Interaction of staphylococci with bone. Int J Med Microbiol (2009) 1.23
Sigma factor B and RsbU are required for virulence in Staphylococcus aureus-induced arthritis and sepsis. Infect Immun (2004) 1.23
The Genomic Aspect of Virulence, Sepsis, and Resistance to Killing Mechanisms in Staphylococcus aureus. Curr Infect Dis Rep (2002) 1.22
Phenol-soluble modulins--critical determinants of staphylococcal virulence. FEMS Microbiol Rev (2014) 1.21
Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains. Clin Diagn Lab Immunol (1995) 1.21
Attenuating Staphylococcus aureus virulence gene regulation: a medicinal chemistry perspective. J Med Chem (2013) 1.20
Ethanol prevents development of destructive arthritis. Proc Natl Acad Sci U S A (2006) 1.18
Staphylococcus aureus SarA is a regulatory protein responsive to redox and pH that can support bacteriophage lambda integrase-mediated excision/recombination. Mol Microbiol (2009) 1.17
Role of the staphylococcal accessory gene regulator (sar) in septic arthritis. Infect Immun (1996) 1.17
Investigations into sigmaB-modulated regulatory pathways governing extracellular virulence determinant production in Staphylococcus aureus. J Bacteriol (2006) 1.17
Current concepts review: septic arthritis of the knee pathophysiology, diagnostics, and therapy. Wien Klin Wochenschr (2011) 1.17
Staphylococcus aureus agr genotypes with enterotoxin production capabilities can resist neutrophil bactericidal activity. Infect Immun (2001) 1.11
Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2011) 1.09
Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun (1994) 1.08
Identification of Staphylococcus aureus AgrD residues required for autoinducing peptide biosynthesis. J Biol Chem (2009) 1.06
Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol (1999) 1.06
Identification of a novel essential two-component signal transduction system, YhcSR, in Staphylococcus aureus. J Bacteriol (2005) 1.05
Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus. Infect Immun (2007) 1.04
Antibiotic-mediated selection of quorum-sensing-negative Staphylococcus aureus. MBio (2013) 1.03
Staphylococcal proteases aid in evasion of the human complement system. J Innate Immun (2013) 1.02
Targeting agr- and agr-Like quorum sensing systems for development of common therapeutics to treat multiple gram-positive bacterial infections. Sensors (Basel) (2013) 1.01
Transcriptional regulation of the Staphylococcus aureus collagen adhesion gene, cna. Infect Immun (1997) 1.00
The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections. Expert Opin Ther Targets (2012) 0.98
Heterogeneity in ess transcriptional organization and variable contribution of the Ess/Type VII protein secretion system to virulence across closely related Staphylocccus aureus strains. Mol Microbiol (2014) 0.98
Allele-dependent differences in quorum-sensing dynamics result in variant expression of virulence genes in Staphylococcus aureus. J Bacteriol (2012) 0.98
An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in Staphylococcus aureus. Antimicrob Agents Chemother (2012) 0.98
Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic Infections. PLoS Pathog (2015) 0.97
Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther (2006) 0.95
Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice. Arthritis Res Ther (2009) 0.93
Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis. Clin Exp Immunol (1999) 0.92
Deciphering the intracellular metabolism of Listeria monocytogenes by mutant screening and modelling. BMC Genomics (2010) 0.90
Induction of virulence gene expression in Staphylococcus aureus by pulmonary surfactant. Infect Immun (2014) 0.87
CvfA protein and polynucleotide phosphorylase act in an opposing manner to regulate Staphylococcus aureus virulence. J Biol Chem (2014) 0.86
Are B lymphocytes of importance in severe Staphylococcus aureus infections? Infect Immun (2000) 0.86
Prevalence and accessory gene regulator (agr) analysis of vancomycin-intermediate Staphylococcus aureus among methicillin-resistant isolates in Taiwan--SMART program, 2003. Eur J Clin Microbiol Infect Dis (2010) 0.86
Assessment of virulence diversity of methicillin-resistant Staphylococcus aureus strains with a Drosophila melanogaster infection model. BMC Microbiol (2012) 0.86
Identification of a hydrophobic cleft in the LytTR domain of AgrA as a locus for small molecule interactions that inhibit DNA binding. Biochemistry (2012) 0.85
Accessory gene regulator group polymorphisms in methicillin-resistant Staphylococcus aureus: an association with clinical significance. Yonsei Med J (2007) 0.85
Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin Exp Immunol (2002) 0.84
Pseudomonas aeruginosa induces pigment production and enhances virulence in a white phenotypic variant of Staphylococcus aureus. Infect Drug Resist (2013) 0.84
Capsaicin protects mice from community-associated methicillin-resistant Staphylococcus aureus pneumonia. PLoS One (2012) 0.83
Random mutagenesis and topology analysis of the autoinducing peptide biosynthesis proteins in Staphylococcus aureus. Mol Microbiol (2012) 0.82
Staphylococcus aureus biofilm: a complex developmental organism. Mol Microbiol (2017) 0.82
The surface protein Pls of methicillin-resistant Staphylococcus aureus is a virulence factor in septic arthritis. Infect Immun (2005) 0.81
Differential arthritogenicity of Staphylococcus aureus strains isolated from biological samples. BMC Infect Dis (2013) 0.81
Quorum-sensing regulation in staphylococci-an overview. Front Microbiol (2015) 0.81
Staphylococcus aureus formyl-methionyl transferase mutants demonstrate reduced virulence factor production and pathogenicity. Antimicrob Agents Chemother (2013) 0.81
N-terminal ArgD peptides from the classical Staphylococcus aureus Agr system have cytotoxic and proinflammatory activities. Chem Biol (2014) 0.81
Staphylococcus aureus interaction with phospholipid vesicles--a new method to accurately determine accessory gene regulator (agr) activity. PLoS One (2014) 0.81
Antibodies to Staphylococcus aureus bone sialoprotein-binding protein indicate infectious osteomyelitis. Clin Vaccine Immunol (2009) 0.80
Generation of a Novel Staphylococcus aureus Ghost Vaccine and Examination of Its Immunogenicity against Virulent Challenge in Rats. Infect Immun (2015) 0.80
Combined antibiotic and free radical trap treatment is effective at combating Staphylococcus-aureus-induced septic arthritis. Arthritis Res (2002) 0.80
Role of quorum sensing in bacterial infections. World J Clin Cases (2015) 0.80
Avirulence and immunogenicity in mice of a bovine mastitis Staphylococcus aureus mutant. Can J Vet Res (1998) 0.80
Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteases. PLoS One (2013) 0.79
The catabolite control protein E (CcpE) affects virulence determinant production and pathogenesis of Staphylococcus aureus. J Biol Chem (2014) 0.78
Evaluation of capsular and acapsular strains of S. aureus in an experimental brain abscess model. J Neuroimmunol (2009) 0.78
The Treponema denticola AtcR LytTR domain-containing response regulator interacts with three architecturally distinct promoter elements: implications for understanding the molecular signaling mechanisms that drive the progression of periodontal disease. Mol Oral Microbiol (2014) 0.78
Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology (1967) 14.24
Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen Genet (1986) 9.54
Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc Natl Acad Sci U S A (1992) 6.95
A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Anal Biochem (1982) 6.53
Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J Biol Chem (1984) 5.94
The role of the delta-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. EMBO J (1990) 5.55
Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct (1988) 4.54
Cloning of a chromosomal locus (exp) which regulates the expression of several exoprotein genes in Staphylococcus aureus. Mol Gen Genet (1988) 3.96
Identification and nucleotide sequence of the delta-lysin gene, hld, adjacent to the accessory gene regulator (agr) of Staphylococcus aureus. Mol Gen Genet (1989) 3.80
Bacterial arthritis. N Engl J Med (1985) 3.61
Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol (1988) 3.51
Rapid methods for isolation of human plasma fibronectin. Thromb Res (1982) 3.35
Staphylococcus aureus. The persistent pathogen (first of two parts). N Engl J Med (1984) 3.15
Phenotypic characterization of xpr, a global regulator of extracellular virulence factors in Staphylococcus aureus. Infect Immun (1993) 3.05
Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin. J Biol Chem (1992) 2.99
Presence of laminin receptors in Staphylococcus aureus. Science (1985) 2.79
Cloning and expression of the gene for a fibronectin-binding protein from Staphylococcus aureus. EMBO J (1987) 2.79
Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch Biochem Biophys (1975) 2.64
Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun (1992) 2.64
Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J (1985) 2.55
Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect Immun (1989) 2.42
Experimental Staphylococcus aureus arthritis in mice. Infect Immun (1991) 2.24
Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun (1991) 1.99
Specific binding of bone sialoprotein to Staphylococcus aureus isolated from patients with osteomyelitis. Eur J Biochem (1989) 1.63
Fibrinogen-binding protein/clumping factor from Staphylococcus aureus. Infect Immun (1989) 1.56
Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol (1992) 1.53
Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium. J Clin Invest (1984) 1.43
Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the Lys form of the ligand. Eur J Biochem (1990) 1.37
Staphylococcal alpha toxin--recent advances. Toxicon (1988) 1.35
Selective binding of bone matrix sialoprotein to Staphylococcus aureus in osteomyelitis. Lancet (1987) 1.34
Animal models of infectious arthritis. Clin Rheum Dis (1986) 1.16
Vitronectin-binding surface proteins of Staphylococcus aureus. Zentralbl Bakteriol (1992) 1.13
Recombinant human tumor necrosis factor alpha promotes adherence of Staphylococcus aureus to cultured human endothelial cells. Infect Immun (1991) 1.13
Septic arthritis. Staphylococcal induction of chondrocyte proteolytic activity. Arthritis Rheum (1990) 0.98
Biochemical mechanisms of articular destruction. Rheum Dis Clin North Am (1987) 0.91
Bacterial arthritis. A staphylococcal proteoglycan-releasing factor. Arthritis Rheum (1986) 0.88
A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods (1983) 6.71
The role of the delta-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. EMBO J (1990) 5.55
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06
Cloning of a chromosomal locus (exp) which regulates the expression of several exoprotein genes in Staphylococcus aureus. Mol Gen Genet (1988) 3.96
Identification and nucleotide sequence of the delta-lysin gene, hld, adjacent to the accessory gene regulator (agr) of Staphylococcus aureus. Mol Gen Genet (1989) 3.80
Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J (1995) 3.64
Global regulation of Staphylococcus aureus genes by Rot. J Bacteriol (2003) 3.02
Transcriptional control of the agr-dependent virulence gene regulator, RNAIII, in Staphylococcus aureus. Mol Microbiol (1996) 2.69
Influence of cultivation conditions on the production of extracellular proteins by Staphylococcus aureus. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 2.66
Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun (1992) 2.64
Identification and characterization of SarH1, a new global regulator of virulence gene expression in Staphylococcus aureus. Mol Microbiol (2000) 2.57
The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun (1994) 2.44
Experimental Staphylococcus aureus arthritis in mice. Infect Immun (1991) 2.24
Fibronectin receptors from Staphylococcus aureus. J Biol Chem (1983) 2.19
Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun (1997) 2.08
Decreased amounts of cell wall-associated protein A and fibronectin-binding proteins in Staphylococcus aureus sarA mutants due to up-regulation of extracellular proteases. Infect Immun (2001) 2.07
Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity. Infect Immun (1993) 2.05
Binding of fibronectin to Staphylococcus strains. Infect Immun (1983) 1.96
Binding of fibronectin to the surface of group A, C, and G streptococci isolated from human infections. Eur J Clin Microbiol (1982) 1.91
A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family. Biochem J (2000) 1.82
The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun (1997) 1.80
Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum (1990) 1.75
Transcription of Staphylococcus aureus fibronectin binding protein genes is negatively regulated by agr and an agr-independent mechanism. J Bacteriol (1997) 1.72
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol (1999) 1.68
Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun (2000) 1.65
Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.62
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med (1999) 1.61
Formation of bacteriolytic enzymes in batch and continuous culture of Staphylococcus aureus. J Bacteriol (1970) 1.58
Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke (1995) 1.58
Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun (1999) 1.52
Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol (1997) 1.51
Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis (2003) 1.38
Studies on extracellular proteolytic enzymes from Staphylococcus aureus. I. Purification and characterization of one neutral and one alkaline protease. Biochim Biophys Acta (1973) 1.38
Genistein as an anti-inflammatory agent. Inflamm Res (2003) 1.35
Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J Clin Invest (1998) 1.35
Regulation of agr-dependent virulence genes in Staphylococcus aureus by RNAIII from coagulase-negative staphylococci. J Bacteriol (1998) 1.34
Selective binding of bone matrix sialoprotein to Staphylococcus aureus in osteomyelitis. Lancet (1987) 1.34
Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A (1994) 1.33
Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci. Eur J Immunol (1994) 1.32
The formation of extracellular proteolytic enzymes by Staphylococcus aureus. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 1.31
Specific attachment of Staphylococcus aureus to immobilized fibronectin. Infect Immun (1986) 1.31
The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism. Infect Immun (2001) 1.30
Decay of ompA mRNA and processing of 9S RNA are immediately affected by shifts in growth rate, but in opposite manners. J Bacteriol (1992) 1.30
The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology (1998) 1.30
Mice with the xid B cell defect are less susceptible to developing Staphylococcus aureus-induced arthritis. J Immunol (1995) 1.28
Addition of corticosteroids to antibiotic treatment ameliorates the course of experimental Staphylococcus aureus arthritis. Arthritis Rheum (1996) 1.27
Secretory S complex of Bacillus subtilis: sequence analysis and identity to pyruvate dehydrogenase. J Bacteriol (1990) 1.27
GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes: direct activation of Cdc42. J Biol Chem (2001) 1.27
Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol (1990) 1.26
Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J Immunol (1995) 1.26
Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus (2000) 1.26
Studies on extracellular proteolytic enzymes from Staphylococcus aureus. II. Isolation and characterization of an EDTA-sensitive protease. Biochim Biophys Acta (1973) 1.25
A demineralization procedure for immunohistopathological use. EDTA treatment preserves lymphoid cell surface antigens. J Immunol Methods (1986) 1.25
Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances. J Immunol Methods (1984) 1.21
Role of T lymphocytes in experimental Staphylococcus aureus arthritis. Scand J Immunol (1994) 1.19
Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study. Clin Exp Immunol (1984) 1.19
Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol (1992) 1.19
Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis (2006) 1.18
Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J Clin Lab Immunol (1983) 1.18
Hydrolysis of casein by three extracellular proteolytic enzymes from Staphylococcus aureus, strain V8. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 1.18
TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J Immunol (1998) 1.18
Role of the staphylococcal accessory gene regulator (sar) in septic arthritis. Infect Immun (1996) 1.17
Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology (1987) 1.17
Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue. J Immunol (1989) 1.16
Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis (2001) 1.16
The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool. Scand J Immunol (2007) 1.16
Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology (1989) 1.15
Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol (1992) 1.14
Impaired cutaneous delayed-type hypersensitivity in autoimmune MRL lpr/lpr mice. Int Arch Allergy Appl Immunol (1986) 1.13
Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation (1993) 1.12
Simultaneous induction of rheumatoid factor- and antigen-specific antibody-secreting cells during the secondary immune response in man. Clin Exp Immunol (1985) 1.12
Polyclonal B-cell activation by an arthritogenic Staphylococcus aureus strain: contribution of T-cells and monokines. Cell Immunol (1993) 1.11
Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology (1996) 1.11
Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia. Acta Neurol Scand (2001) 1.10
Toxic shock syndrome toxin 1 contributes to the arthritogenicity of Staphylococcus aureus. J Infect Dis (1994) 1.09
Role of macrophages in Staphylococcus aureus-induced arthritis and sepsis. Arthritis Rheum (2000) 1.09
Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun (1994) 1.08
Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J Infect Dis (1999) 1.08
Detection of proteolytic activity after isoelectric focusing in polyacrylamide gel. Biochim Biophys Acta (1973) 1.07
Retarded RNA turnover in Escherichia coli: a means of maintaining gene expression during anaerobiosis. Mol Microbiol (1993) 1.07
Evaluation of gliadin antibodies for detection of coeliac disease. Scand J Gastroenterol (1983) 1.07
Generation of monoclonal rheumatoid factors after immunization with collagen II-anti-collagen II immune complexes. An anti-idiotypic antibody to anti-collagen II is also a rheumatoid factor. Scand J Immunol (1986) 1.07
Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol (1999) 1.06